Fusion Pharmaceuticals News

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

20.03.24	Recap: Fusion Pharmaceuticals Q4 Earnings (Benzinga)
20.03.24	Unveiling 11 Analyst Insights On Fusion Pharmaceuticals (Benzinga)
19.03.24	MÄRKTE USA/Positive Stimmung für Aktien vor Fed-Aussagen - Marktzinsen sinken (Dow Jones)
19.03.24	Fusion Pharma-Aktie +99%: AstraZeneca kauft Fusion Pharmaceuticals (Dow Jones) AstraZeneca erwirbt Fusion Pharmaceuticals.» mehr
19.03.24	MÄRKTE USA/Akteure an der Wall Street im Wartemodus (Dow Jones)
19.03.24	MÄRKTE USA/Uneinheitlich - Nasdaq-Indizes schwächeln (Dow Jones)
19.03.24	MÄRKTE USA/Leichtes Minus - Fed-Entscheid im Fokus (Dow Jones)
19.03.24	Why Fusion Pharmaceuticals Shares Are Trading Higher By Around 95%; Here Are 20 Stocks Moving Premarket (Benzinga)
19.03.24	MARKT USA/Leichte Abgaben - Fed-Entscheid im Fokus (Dow Jones)
19.03.24	Pharmaindustrie: Astra-Zeneca übernimmt Krebsspezialisten Fusion Pharmaceuticals (Handelsblatt)
19.03.24	AstraZeneca to buy Fusion Pharmaceuticals for up to $2.4 billion (MarketWatch)
04.03.24	A Glimpse Into The Expert Outlook On Fusion Pharmaceuticals Through 7 Analysts (Benzinga)
26.01.24	Expert Outlook: Fusion Pharmaceuticals Through The Eyes Of 6 Analysts (Benzinga)
27.12.23	Recent M&A Bodes Well For Targeted Cancer Therapy Player Fusion Pharmaceuticals, Analyst Say AstraZeneca Is Favorably Positioned (Benzinga)
27.12.23	A Closer Look at 4 Analyst Recommendations For Fusion Pharmaceuticals (Benzinga)
12.08.21	Fusion Pharmaceuticals and TRIUMF Announce Expanded R&D Collaboration for Actinium Supply Production (PR Newswire)
12.08.21	Fusion Pharmaceuticals and TRIUMF Announce Expanded R&D Collaboration for Actinium Supply Production (PR Newswire)
10.08.21	Fusion Pharmaceuticals Announces Second Quarter 2021 Financial Results and Business Update (PR Newswire)
10.08.21	Fusion Pharmaceuticals Announces Second Quarter 2021 Financial Results and Business Update (PR Newswire)
05.08.21	Fusion Pharmaceuticals to Participate in the 2021 Wedbush PacGrow Healthcare Virtual Conference (PR Newswire)
05.08.21	Fusion Pharmaceuticals to Participate in the 2021 Wedbush PacGrow Healthcare Virtual Conference (PR Newswire)
28.07.21	Fusion Pharmaceuticals Announces FDA Clearance of IND for FPI-1966, an Investigational Radiopharmaceutical for the Treatment of Head and Neck and Bladder Cancers Expressing FGFR3 (PR Newswire)
28.07.21	Fusion Pharmaceuticals Announces FDA Clearance of IND for FPI-1966, an Investigational Radiopharmaceutical for the Treatment of Head and Neck and Bladder Cancers Expressing FGFR3 (PR Newswire)
07.07.21	Fusion Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (PR Newswire)
07.07.21	Fusion Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (PR Newswire)
14.06.21	Fusion Pharmaceuticals Announces Preliminary Safety and Dosimetry Results from its Single-Dose Portion of the Phase 1 Study of FPI-1434 (PR Newswire)
14.06.21	Fusion Pharmaceuticals Announces Preliminary Safety and Dosimetry Results from its Single-Dose Portion of the Phase 1 Study of FPI-1434 (PR Newswire)
07.06.21	Fusion Pharmaceuticals Appoints Isabelle Dussault, Ph.D. as Senior Vice President, Research (PR Newswire)
07.06.21	Fusion Pharmaceuticals Appoints Isabelle Dussault, Ph.D. as Senior Vice President, Research (PR Newswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Sonova Hldg	295.60	0.96 %	K V
Lonza Grp	531.00	0.53 %	K V
Alcon	76.02	0.34 %	K V
Roche Hldg G	247.40	0.28 %	K V
ABB	48.86	0.27 %	K V
Swisscom	498.40	-0.62 %	K V
UBS Group	26.71	-0.67 %	K V
Zurich Insur Gr	533.00	-0.97 %	K V
Holcim	86.10	-1.01 %	K V
Sika	213.20	-2.47 %	K V

mehr

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Nachrichten zu Fusion Pharmaceuticals Inc Registered Shs

Aktien Top/Flop

Fusion Pharmaceuticals Peer Group Nachrichten

Meistgelesene Nachrichten